Association of soluble intercellular adhesion molecule 1 with neurological deterioration of ischemic stroke: The Chongqing stroke study

Cerebrovascular Diseases

Volumn 21, Issue 1-2, 2006, Pages 67-73

  Wang, John Y J ^a   Zhou, David H D ^a   Li, Jingcheng ^a   Zhang, Meng ^a   Deng, Juan ^a   Gao, Changyue ^a   Li, Jing ^a   Lian, Yan ^a   Chen, Man'e ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ischemic stroke, deterioration; Soluble intercellular adhesion molecule 1

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STROKE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHINA; COHORT STUDIES; E-SELECTIN; FEMALE; HOSPITALIZATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 30944446356     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090005     Document Type: Article

References (40)

1. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C: Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol 1995;52:670-675.
2. Davalos A, Cendra E, Teruel J, Martinez M, Genis D: Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865-1869.
3. Castillo J, Rodriguez I: Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;17(suppl 1):7-18.
4. Castillo J, Leira R: Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? Cerebrovasc Dis 2001;11(suppl 1):40-48.
5. Castillo J: Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis 1999;9(suppl 3):1-8.
6. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M: Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large-and small-vessel disease. Stroke 1999;30:1647-1650.
7. Selakovic V, Colic M, Jovanovic M, Raicevic R, Jovicic A: Cerebrospinal fluid and plasma concentration of soluble intercellular adhesion molecule 1, vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule in patients with acute ischemic brain disease. Vojnosanit Pregl 2003;60:139-146.
8. Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M: Circulating selectin-and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995;26:1361-1364.
9. Clark WM, Zivin JA: Antileukocyte adhesion therapy: preclinical trials and combination therapy. Neurology 1997;49:S32-38.
10. Zhou DH, Wang JY, Li J, Deng J, Gao C, Chen M: Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study. J Neurol 2004;251:421-427.
11. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST-Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
12. Zhou H, Deng J, Li J, Wang Y, Zhang M, He H: Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in China. Age Ageing 2003;32:205-210.
13. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, Rohlfs M, Suhr H, Fiehn W, Becher H, Hacke W: Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995;26:373-379.
14. Chamorro A, Cervera A, Castillo J, Davalos A, Aponte JJ, Planas AM: Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients. Neurosci Lett 2002;328:229-232.
15. Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.
16. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J: Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30:2631-2636.
17. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Effect of blood pressure and diabetes on stroke in progression. Lancet 1994;344:156-159.
18. Davalos A, Castillo J, Pumar JM, Noya M: Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997;7:64-69.
19. Frijns CJ, Kappelle LJ: Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002;33:2115-2122.
20. Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R: Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997;28:2214-2218.
21. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P: A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998;29:2129-2135.
22. Shyu KG, Chang H, Lin CC: Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 1997;244:90-93.
23. Clark WM, Coull BM, Briley DP, Mainolfi E, Rothlein R: Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol 1993;44:123-125.
24. Mori E, del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE: Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992;23:712-718.
25. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ: P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994;25:202-211.
26. del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-1283.
27. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM: Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000;6:1355-1361.
28. Akman HO, Zhang H, Siddiqui MA, Solomon W, Smith EL, Batuman OA: Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells. Blood 2001;98:3324-3331.
29. Clark WM: Cytokines and reperfusion injury. Neurology 1997;49:S10-14.
30. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, Granger DN: Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the post-ischemic cerebral microcirculation. Stroke 2003;34:1777-1782.
31. Pierangeli SS, Espinola RG, Liu X, Harris EN: Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 2001;88:245-250.
32. Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE: Intravenous ancrod for treatment of acute ischemic stroke: The STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 2000;283:2395-2403.
33. Chen J, Ma Y, Liang H: Effect of different injections of Chinese herbal medicine on stress hormones and immune cell factors in patients of type 2 diabetes mellitus complicated with acute cerebral infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20:815-817.
34. 31P-magnetic resonance spectroscopy. J Tradit Chin Med 2001;21:59-67.
35. Lin S, Lian Q, Liang H: Clinical study on active factors of vascular endothelial cells in acute cerebral infarction patients and therapeutical effect of activating blood stasis. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998;18:392-395.
36. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA: Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003;34:2543-2548.
37. Enlimomab Acute Stroke Trial Investigators: Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001;57:1428-1434.
38. Becker KJ: Anti-leukocyte antibodies: Leukarrest (Hu23F2G) and enlimomab (R6.5) in acute stroke. Curr Med Res Opin 2002;18(suppl 2):s18-22.
39. Price CJ, Warburton EA, Menon DK: Human cellular inflammation in the pathology of acute cerebral ischaemia. J Neurol Neurosurg Psychiatry 2003;74:1476-1484.
40. Furuya K, Takeda H, Azhar S, McCarron RM, Chen Y, Ruetzler CA, Wolcott KM, De Graba TJ, Rothlein R, Hugli TE, del Zoppo GJ, Hallenbeck JM: Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 2001;32:2665-2674.